These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14767645)

  • 1. Gelatinase expression in ocular surface disorders.
    Sakimoto T; Shoji J; Kanno H; Sawa M
    Jpn J Ophthalmol; 2004; 48(1):17-22. PubMed ID: 14767645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P; He J; Axelrad TW; Bazan HE
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
    J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
    Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
    Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas.
    Ye HQ; Maeda M; Yu FS; Azar DT
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2894-9. PubMed ID: 10967042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas.
    Collier SA; Madigan MC; Penfold PL
    Curr Eye Res; 2000 Aug; 21(2):662-8. PubMed ID: 11148603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis.
    Zhang H; Li C; Baciu PC
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):955-62. PubMed ID: 11923234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M; Thomas LE; Wheeler SE; Curry TE
    Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
    Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
    Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
    Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of matrix metalloproteinases in the murine zymosan-induced multiple organ dysfunction syndrome.
    Volman TJ; Goris RJ; Lomme RM; DeGroot J; Verhofstad AA; Hendriks T
    J Pathol; 2004 Aug; 203(4):968-75. PubMed ID: 15259001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented membrane type 1 matrix metalloproteinase (MT1-MMP):MMP-2 messenger RNA ratio in gastric carcinomas with poor prognosis.
    Caenazzo C; Onisto M; Sartor L; Scalerta R; Giraldo A; Nitti D; Garbisa S
    Clin Cancer Res; 1998 Sep; 4(9):2179-86. PubMed ID: 9748137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
    Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
    Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
    Afonso AA; Sobrin L; Monroy DC; Selzer M; Lokeshwar B; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2506-12. PubMed ID: 10509643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).
    Fukushima K; Nakamura A; Ueda H; Yuasa K; Yoshida K; Takeda S; Ikeda S
    BMC Musculoskelet Disord; 2007 Jun; 8():54. PubMed ID: 17598883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers.
    Dogru M; Asano-Kato N; Tanaka M; Igarashi A; Shimmura S; Shimazaki J; Okada N; Takano Y; Fukagawa K; Tsubota K; Fujishima H
    Curr Eye Res; 2005 Oct; 30(10):897-908. PubMed ID: 16251127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active form of gelatinases in tear fluidin patients with corneal ulcer or ocular burn.
    Sakimoto T; Shoji J; Sawa M
    Jpn J Ophthalmol; 2003; 47(5):423-6. PubMed ID: 12967855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.